Physician specialty
Maternal-Fetal Medicine (High-Risk Pregnancy)
At a glance
- Practicing in the U.S.
- 3,179
- Per 100,000 residents
- 0.9
- Women
- 56%
- Median years since graduating
- 22
Training path
- College (bachelor’s degree) 4 years
- Medical school (MD or DO) 4 years
- Obstetrics and gynecology residency 4 years
- Maternal-fetal medicine fellowship 3 years
Training after medical school: 7 years. From the start of college: about 15 years.
Usual minimum program lengths from ACGME program requirements. Some doctors take extra research years or a second fellowship.
Who they are
- MD (DOs make up the rest) 94%
- Women 56%
- Graduated 35 or more years ago 25%
- Offer telehealth 1%
- Accept Medicare’s approved amount 94%
Sex and credentials from NPPES. Graduation year, telehealth and Medicare assignment from Medicare Care Compare, which covers clinicians enrolled in Medicare.
Where they practice
What they do most for Medicare patients
- Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina 5,459
- Complete ultrasound scan of pelvis 3,589
- Established patient office or other outpatient visit, 20-29 minutes 765
- Established patient office or other outpatient visit, 30-39 minutes 668
- Urinalysis, manual test 585
- Critical care, first 30-74 minutes 523
- Complete ultrasound of abdomen and pelvis artery and vein blood flow 391
- Cervical or vaginal cancer screening; pelvic and clinical breast examination 277
- Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 266
- Stool analysis for blood to screen for colon tumors 208
- Follow-up ultrasound scan of pregnant uterus 191
- 3d radiographic procedure 176
Services billed to traditional Medicare in 2023 (Physician and Other Practitioners data); drugs given in the office are left out.
What they prescribe most
- Estradiol (Divigel, Estring, Estrogel) 31.2%
- Progesterone, Micronized (Crinone, Progesterone, Prometrium) 11.7%
- Estrogens, Conjugated (Premarin) 5.4%
- Levothyroxine Sodium (Euthyrox, Levo-T, Ermeza) 4.0%
- Valacyclovir Hcl (Valacyclovir, Valtrex) 3.4%
- Oxycodone Hcl (Oxycontin, Roxicodone, Roxybond) 3.2%
- Fluconazole (Diflucan) 2.9%
- Ibuprofen (Caldolor, Ibu) 2.4%
- Medroxyprogesterone Acetate (Depo-Subq Provera 104) 1.9%
- Clobetasol Propionate 1.7%
- Spironolactone (Carospir, Aldactone) 1.5%
- Terconazole 1.5%
- Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) 1.4%
- Nitrofurantoin Monohyd/M-Cryst (Macrobid, Nitrofurantoin Mono-Macro) 1.3%
- Metronidazole (Noritate, Nuvessa, Vandazole) 1.3%
Share of this specialty’s Medicare Part D prescriptions in 2024, including refills. Select a drug to see which of these clinicians prescribe it most, and where.
Hospitals where the most work
- University of Alabama Hospital Birmingham, AL 15 Maternal-Fetal Medicine (High-Risk Pregnancy) at University of Alabama Hospital
- Ohio State University State Health System Columbus, OH 12 Maternal-Fetal Medicine (High-Risk Pregnancy) at Ohio State University State Health System
- Umass Memorial Medical Center/university Campus Worcester, MA 12 Maternal-Fetal Medicine (High-Risk Pregnancy) at Umass Memorial Medical Center/university Campus
- Northwestern Memorial Hospital Chicago, IL 12 Maternal-Fetal Medicine (High-Risk Pregnancy) at Northwestern Memorial Hospital
- Barnes Jewish Hospital Saint Louis, MO 11 Maternal-Fetal Medicine (High-Risk Pregnancy) at Barnes Jewish Hospital
- Memorial Hermann - Texas Medical Center Houston, TX 10 Maternal-Fetal Medicine (High-Risk Pregnancy) at Memorial Hermann - Texas Medical Center
- Women & Infants Hospital of Rhode Island Providence, RI 10 Maternal-Fetal Medicine (High-Risk Pregnancy) at Women & Infants Hospital of Rhode Island
- Ohsu Hospital and Clinics Portland, OR 10 Maternal-Fetal Medicine (High-Risk Pregnancy) at Ohsu Hospital and Clinics
- Beth Israel Deaconess Medical Center Boston, MA 10 Maternal-Fetal Medicine (High-Risk Pregnancy) at Beth Israel Deaconess Medical Center
- Good Samaritan Hospital Cincinnati, OH 9 Maternal-Fetal Medicine (High-Risk Pregnancy) at Good Samaritan Hospital
Clinicians who list the hospital in Medicare Care Compare. The number opens the list of who works there.
Schools they graduated from most
- Columbia University College of Physicians and Surgeons 30
- Medical University of South Carolina College of Medicine 24
- Harvard Medical School 23
- University of Michigan Medical School 23
- Tufts University School of Medicine 22
- University of Texas Southwestern Medical School at Dallas 22
- University of Miami, Lm Miller School of Medicine 21
- New York Medical College 20
- Perelman School of Med at The University of Pennsylvania 20
- Tulane University School of Medicine 20
From Medicare Care Compare (Medicare-enrolled clinicians only).
Industry payments
Drug and device makers reported $758,174 in general payments to 894 clinicians in Maternal-Fetal Medicine (High-Risk Pregnancy) in 2025. See who received the most
Source: CMS Open Payments, program year 2025. A payment is not evidence of wrongdoing.
Research in this field
U.S. researchers published 9,354 articles and reviews in obstetrics and gynecology in 2024–2026.
Journals with the most U.S. papers
- American Journal of Obstetrics and Gynecology Elsevier BV 669
- Gynecologic Oncology Elsevier BV 590
- International Journal of Gynecological Cancer BMJ 381
- Journal of Minimally Invasive Gynecology Elsevier BV 336
- American Journal of Perinatology Thieme Medical Publishers (Germany) 214
- Obstetrics and Gynecology Lippincott Williams & Wilkins 204
- American Journal of Obstetrics & Gynecology MFM Elsevier BV 196
- Cureus Cureus, Inc. 168
- Placenta Elsevier BV 163
- BMC Pregnancy and Childbirth BioMed Central 114
Most-cited recent papers
- Epidemiology and management of gestational diabetes (opens in a new tab) The Lancet, 2024 · cited 493 times · free to read
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial (opens in a new tab) The Lancet, 2024 · cited 433 times
- ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025 (opens in a new tab) The Lancet Oncology, 2025 · cited 398 times · free to read
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial (opens in a new tab) The Lancet, 2024 · cited 235 times
- Pathophysiology from preconception, during pregnancy, and beyond (opens in a new tab) The Lancet, 2024 · cited 200 times · free to read
- Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management (opens in a new tab) International Journal of Molecular Sciences, 2025 · cited 146 times · free to read
- Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care (opens in a new tab) Circulation, 2025 · cited 146 times · free to read
- Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial (opens in a new tab) Annals of Oncology, 2024 · cited 146 times · free to read
From OpenAlex, an open index of research papers. Papers with at least one author at a U.S. institution, classified by subject; the subject covers the whole field, so related specialties share these lists. Citation counts change daily.
Sources: CMS NPPES (counts, sex, credentials), Medicare Care Compare (schools, graduation years, hospitals, telehealth), CMS Medicare Physician & Other Practitioners (2023) and Part D Prescribers (2024), CMS Open Payments (2025), ACGME program requirements (training length), OpenAlex (research), U.S. Census Bureau ACS 2020–2024 (population).